These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 26456011)

  • 21. The role of helioxanthin in inhibiting human hepatitis B viral replication and gene expression by interfering with the host transcriptional machinery of viral promoters.
    Tseng YP; Kuo YH; Hu CP; Jeng KS; Janmanchi D; Lin CH; Chou CK; Yeh SF
    Antiviral Res; 2008 Mar; 77(3):206-14. PubMed ID: 18249449
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficient inhibition of hepatitis B virus replication by small interfering RNAs targeted to the viral X gene in mice.
    Shin D; Kim SI; Kim M; Park M
    Virus Res; 2006 Aug; 119(2):146-53. PubMed ID: 16443303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of hepatitis B virus replication by N-hydroxyisoquinolinediones and related polyoxygenated heterocycles.
    Edwards TC; Lomonosova E; Patel JA; Li Q; Villa JA; Gupta AK; Morrison LA; Bailly F; Cotelle P; Giannakopoulou E; Zoidis G; Tavis JE
    Antiviral Res; 2017 Jul; 143():205-217. PubMed ID: 28450058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The HBV-producing cell line HepG2-4A5: a new in vitro system for studying the regulation of HBV replication and for screening anti-hepatitis B virus drugs.
    Weiss L; Kekulè AS; Jakubowski U; Bürgelt E; Hofschneider PH
    Virology; 1996 Feb; 216(1):214-8. PubMed ID: 8614990
    [TBL] [Abstract][Full Text] [Related]  

  • 25. β-Thujaplicinol inhibits hepatitis B virus replication by blocking the viral ribonuclease H activity.
    Hu Y; Cheng X; Cao F; Huang A; Tavis JE
    Antiviral Res; 2013 Sep; 99(3):221-9. PubMed ID: 23796982
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro characterization of the anti-hepatitis B virus activity and cross-resistance profile of 2',3'-dideoxy-3'-fluoroguanosine.
    Jacquard AC; Brunelle MN; Pichoud C; Durantel D; Carrouée-Durantel S; Trepo C; Zoulim F
    Antimicrob Agents Chemother; 2006 Mar; 50(3):955-61. PubMed ID: 16495257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Whole genome expression profiling of hepatitis B virus-transfected cell line reveals the potential targets of anti-HBV drugs.
    Ding XR; Yang J; Sun DC; Lou SK; Wang SQ
    Pharmacogenomics J; 2008 Feb; 8(1):61-70. PubMed ID: 17505500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phosphorothioate di- and trinucleotides as a novel class of anti-hepatitis B virus agents.
    Iyer RP; Jin Y; Roland A; Morrey JD; Mounir S; Korba B
    Antimicrob Agents Chemother; 2004 Jun; 48(6):2199-205. PubMed ID: 15155222
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis B virus X protein stimulates gene expression selectively from extrachromosomal DNA templates.
    van Breugel PC; Robert EI; Mueller H; Decorsière A; Zoulim F; Hantz O; Strubin M
    Hepatology; 2012 Dec; 56(6):2116-24. PubMed ID: 22744635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. miR146a impairs the IFN-induced anti-HBV immune response by downregulating STAT1 in hepatocytes.
    Hou ZH; Han QJ; Zhang C; Tian ZG; Zhang J
    Liver Int; 2014 Jan; 34(1):58-68. PubMed ID: 23890093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 5'-triphosphate-siRNA activates RIG-I-dependent type I interferon production and enhances inhibition of hepatitis B virus replication in HepG2.2.15 cells.
    Chen X; Qian Y; Yan F; Tu J; Yang X; Xing Y; Chen Z
    Eur J Pharmacol; 2013 Dec; 721(1-3):86-95. PubMed ID: 24099962
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suppression of hepatitis B virus replication by microRNA-199a-3p and microRNA-210.
    Zhang GL; Li YX; Zheng SQ; Liu M; Li X; Tang H
    Antiviral Res; 2010 Nov; 88(2):169-75. PubMed ID: 20728471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-viral effect of a compound isolated from Liriope platyphylla against hepatitis B virus in vitro.
    Huang TJ; Tsai YC; Chiang SY; Wang GJ; Kuo YC; Chang YC; Wu YY; Wu YC
    Virus Res; 2014 Nov; 192():16-24. PubMed ID: 25150190
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibitory effect of the combination of CpG-induced cytokines with lamivudine against hepatitis B virus replication in vitro.
    Vincent IE; Lucifora J; Durantel D; Hantz O; Chemin I; Zoulim F; Trepo C
    Antivir Ther; 2009; 14(1):131-5. PubMed ID: 19320247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selected phenotypic assays used to evaluate antiviral resistance and viral fitness of hepatitis B virus and its variants.
    Glebe D; Geipel A
    Intervirology; 2014; 57(3-4):225-31. PubMed ID: 25034492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reversal of hepatitis B virus-induced immune tolerance by an immunostimulatory 3p-HBx-siRNAs in a retinoic acid inducible gene I-dependent manner.
    Han Q; Zhang C; Zhang J; Tian Z
    Hepatology; 2011 Oct; 54(4):1179-89. PubMed ID: 21721030
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of compounds that inhibit the interaction between core and surface protein of hepatitis B virus.
    Asif-Ullah M; Choi KJ; Choi KI; Jeong YJ; Yu YG
    Antiviral Res; 2006 Jun; 70(2):85-90. PubMed ID: 16487605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiviral activity and hepatoprotection by heme oxygenase-1 in hepatitis B virus infection.
    Protzer U; Seyfried S; Quasdorff M; Sass G; Svorcova M; Webb D; Bohne F; Hösel M; Schirmacher P; Tiegs G
    Gastroenterology; 2007 Oct; 133(4):1156-65. PubMed ID: 17919491
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 5' Triphosphorylated small interfering RNAs control replication of hepatitis B virus and induce an interferon response in human liver cells and mice.
    Ebert G; Poeck H; Lucifora J; Baschuk N; Esser K; Esposito I; Hartmann G; Protzer U
    Gastroenterology; 2011 Aug; 141(2):696-706, 706.e1-3. PubMed ID: 21684282
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of hepatitis B virus X gene expression by 10-23 DNAzymes.
    Hou W; Ni Q; Wo J; Li M; Liu K; Chen L; Hu Z; Liu R; Hu M
    Antiviral Res; 2006 Dec; 72(3):190-6. PubMed ID: 16930733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.